![]() Prolaris Prolaris is a genomic test for predicting prostate cancer aggressiveness developed by Myriad Genetics. | Therapixel Therapixel is a company that designs and commercializes AI-based medical imaging software. | ||
Founding Date | Founding Date 2018 | Founding Date 2010 | Founding Date 2013 |
Type | Type Private | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations New York, US HQ Aventura, US Beverly Hills, US Great Neck, US Irvine, US Las Vegas, US Miami, US see more | Locations Salt Lake City, US HQ | Locations Nice, FR HQ Paris, FR Valbonne, FR Chicago, US |
Employees | Employees 913% increase | Employees N/A | Employees 492% decrease |
Funding | |||
Latest funding round | Latest funding round $ 18m (about 6 years ago) | Latest funding round N/A | Latest funding round $ 5.7m (about 7 years ago) |
Total funding raised | Total funding raised $ 22m | Total funding raised N/A | Total funding raised $ 6.3m |

Prolaris is a genomic test for predicting prostate cancer aggressiveness developed by Myriad Genetics.
View companyTherapixel is a company that designs and commercializes AI-based medical imaging software.
View company